Zim Laboratories Limited (ZIMLAB) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Zim Laboratories Limited (ZIMLAB) has a cash flow conversion efficiency ratio of 0.036x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs81.71 Million ≈ $883.66K USD) by net assets (Rs2.26 Billion ≈ $24.44 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Zim Laboratories Limited defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Zim Laboratories Limited - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how Zim Laboratories Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Zim Laboratories Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zim Laboratories Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ittifak Holding A.S.
IS:LRSHO
|
-0.028x |
|
Samsung Climat
KO:006660
|
0.009x |
|
LiveOne Inc
NASDAQ:LVO
|
0.215x |
|
Bound and Beyond PCL
BK:BEYOND-R
|
N/A |
|
Genie Music Corporation
KQ:043610
|
0.050x |
|
PTL Enterprises Limited
NSE:PTL
|
0.025x |
|
Quantum X Labs Inc.
NASDAQ:QXL
|
-0.028x |
|
Safety Shot Inc
NASDAQ:SHOT
|
-0.072x |
Annual Cash Flow Conversion Efficiency for Zim Laboratories Limited (2013–2025)
The table below shows the annual cash flow conversion efficiency of Zim Laboratories Limited from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Zim Laboratories Limited.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs2.52 Billion ≈ $27.28 Million |
Rs411.55 Million ≈ $4.45 Million |
0.163x | +139.30% |
| 2024-03-31 | Rs2.39 Billion ≈ $25.82 Million |
Rs162.78 Million ≈ $1.76 Million |
0.068x | -63.59% |
| 2023-03-31 | Rs2.00 Billion ≈ $21.67 Million |
Rs375.19 Million ≈ $4.06 Million |
0.187x | -33.13% |
| 2022-03-31 | Rs1.76 Billion ≈ $19.00 Million |
Rs492.06 Million ≈ $5.32 Million |
0.280x | +41.33% |
| 2021-03-31 | Rs1.61 Billion ≈ $17.38 Million |
Rs318.51 Million ≈ $3.44 Million |
0.198x | +39.07% |
| 2020-03-31 | Rs1.54 Billion ≈ $16.64 Million |
Rs219.15 Million ≈ $2.37 Million |
0.142x | -38.25% |
| 2019-03-31 | Rs1.51 Billion ≈ $16.34 Million |
Rs348.65 Million ≈ $3.77 Million |
0.231x | -13.92% |
| 2018-03-31 | Rs1.37 Billion ≈ $14.77 Million |
Rs366.13 Million ≈ $3.96 Million |
0.268x | -1.11% |
| 2017-03-31 | Rs1.18 Billion ≈ $12.80 Million |
Rs320.71 Million ≈ $3.47 Million |
0.271x | +21.46% |
| 2016-03-31 | Rs983.37 Million ≈ $10.63 Million |
Rs219.43 Million ≈ $2.37 Million |
0.223x | +276.37% |
| 2015-03-31 | Rs942.10 Million ≈ $10.19 Million |
Rs55.85 Million ≈ $604.04K |
0.059x | +105.44% |
| 2014-03-31 | Rs1.16 Billion ≈ $12.55 Million |
Rs33.48 Million ≈ $362.11K |
0.029x | +113.30% |
| 2013-03-31 | Rs1.07 Billion ≈ $11.55 Million |
Rs-231.81 Million ≈ $-2.51 Million |
-0.217x | -- |
About Zim Laboratories Limited
ZIM Laboratories Limited engages in the development, manufacture, and supply of generic pharmaceutical and nutraceutical products in India and internationally. It provides its products in pre- formulation intermediates and finished formulations in the oral solid dosage forms, such as pellets, taste-masked powders, granules, tablets, capsules, dry syrup, and oral thin films. The company offers the… Read more